🇺🇬 Uganda Prevalência de mutilação genital feminina
Uganda Prevalência de mutilação genital feminina was 0.30 in 2016, down 78.6% from 2011, according to World Bank data. The 10-year average is 0.77. Historical data available from 2006 to 2016 (3 data points). The all-time high was 1.40 in 2011.
Source: World Bank World Development Indicators • 2006–2016 • 3 data points • Health
Latest Value
0.30
2016
Year-on-Year
-78.6%
vs 2011
10-Year Average
0.77
2007–2016
Range
High: 1.40 (2011)
Low: 0.30 (2016)
Uganda Prevalência de mutilação genital feminina (%) — 2006 to 2016
Loading chart...
About this Indicator
Percentage of women aged 15–49 who have gone through partial or total removal of the female external genitalia or other injury to the female genital organs for cultural or other non-therapeutic reasons.
Historical Data Table
| Year | Value |
|---|---|
| 2016 | 0.30 |
| 2011 | 1.40 |
| 2006 | 0.60 |
Embed this chart
Copy and paste this code to embed the chart on your website:
<iframe src="https://nationstat.com/pt/country/uganda/female-genital-mutilation-prevalence" width="800" height="500" frameborder="0"></iframe>Compare with Other Countries
🇧🇯Benin
9.202014
🇧🇫Burkina Faso
56.102021
🇨🇫República Centro-Africana
21.602019
🇨🇮Costa do Marfim
36.702016
🇨🇲Camarões
1.402004
🇩🇯Djibuti
90.102019
🇪🇬Egito
87.202015
🇪🇷Eritreia
83.002010
🇪🇹Etiópia
65.202016
🇬🇭Gana
2.402018
🇬🇳Guiné
94.502018
🇬🇲Gâmbia
72.602020
🇬🇼Guiné-Bissau
52.102019
🇮🇶Iraque
7.402018
🇰🇪Quênia
14.802022
🇱🇷Libéria
31.802020
🇲🇻Maldivas
12.902017
🇲🇱Mali
88.602018
🇲🇷Mauritânia
63.902021
🇳🇪Níger
2.002012
🇳🇬Nigéria
15.102021
🇸🇩Sudão
86.602014
🇸🇳Senegal
20.102023
🇸🇱Serra Leoa
83.002019
🇸🇴Somália
99.202020
🇹🇩Chade
34.102019
🇹🇬Togo
3.102017
🇹🇿Tanzânia
8.202022
🇺🇬Uganda
0.302016
🇾🇪Iêmen
18.502013
Related Indicators
Adultos (15+ anos) e crianças (0-14) recentemente infectados por HIV
37.0K
2024
Adultos (idades 15-49) recentemente infectados por HIV
30.0K
2024
Taxa de fertilidade de adolescentes (nascimentos por 1.000 mulheres de 15 a 19 anos de idade)
107.0
2023
Cobertura de terapia antirretroviral para PTMI (% mulheres grávidas com HIV)
100.0
2024
Cobertura de terapia antirretroviral (% pessoas com HIV)
85.0
2024